Mitophagy at the crossroads of cancer development: Exploring the role of mitophagy in tumor progression and therapy resistance
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Mitophagy, the removal of damaged mitochondria, is vital for cell survival and cancer progression. Understanding mitophagy in cancer therapy may reveal new strategies for treating resistant tumors.
Area Of Science
- Cell Biology
- Molecular Biology
- Cancer Research
Background
- Mitochondria are essential for cellular survival, especially under stress.
- Mitophagy, selective mitochondrial removal, maintains cellular homeostasis and prevents damage.
- While studied in neurodegeneration, mitophagy's role in cancer is increasingly recognized.
Purpose Of The Study
- To provide an overview of mitophagy's role in cancer biology.
- To explore mitophagy's potential as a cancer therapy target.
- To highlight the interaction between cancer therapy and mitophagy.
Main Methods
- Literature review and synthesis of current research on mitophagy in cancer.
- Analysis of mitophagy's impact on carcinogenesis.
- Examination of mitophagy's role in cancer therapy response.
Main Results
- Mitophagy perturbations contribute to cancer hallmarks like metabolic plasticity and stemness.
- Mitophagy influences cancer-associated fibroblast metabolism and immunomodulation.
- Mitophagy generally promotes cell survival, especially under cancer therapy stress.
Conclusions
- Mitophagy is a critical regulator in cancer biology, impacting multiple cancer hallmarks.
- Targeting mitophagy presents a promising avenue for novel cancer therapeutics.
- Further insight into cancer therapy-mitophagy interactions could lead to treatments for therapy-resistant cancers.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...